Albavera-Hernández C., Rodríguez JM, Idrovo AJSafety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials. Clin Rehabil2009; 23: 394-407.
2.
Redman TA, Finn JC, Bremner AP, Valentine J.Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy. J Paediatr Child Health2008; 44: 409-14.
3.
Redman TA, Gibson N., Finn JC, Bremner AP, Valentine J., Thickbroom GWUpper limb corticomotor projections and physiological changes that occur with botulinum toxin - A therapy in children with hemiplegic cerebral palsy. Eur J Neurol2008; 15: 787-91.
4.
Moore AP, Ade-Hall RA, Smith CT, Rosenbloom L., Walsh HP, Mohamed K., Williamson PRTwo-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. Neurology2008; 71: 122-28.
5.
Ashcroft R.What is clinical effectiveness?Stud Hist Phil Biol Biomed Sci2002; 33: 219-33.
